Hematology research in King of Prussia, Pennsylvania

Dr. Tracey F. Jubelirer, MD is a reputable medical institution located at 950 Pulaski Drive in King of Prussia, Pennsylvania, United States. Dr. Jubelirer is a highly skilled and experienced doctor specializing in providing top-quality healthcare services to her patients. With a focus on promoting wellness and treating a wide range of medical conditions, Dr. Jubelirer and her team strive to deliver personalized care and compassionate support to all individuals who seek their help. Whether you are in need of a routine check-up, specialized treatment, or ongoing medical care, Dr. Tracey F. Jubelirer, MD is dedicated to helping you achieve optimal health and well-being.

David H. Henry, MD is a reputable medical institution located in North Radnor, Pennsylvania, United States. Specializing in providing top-quality healthcare services, Dr. David H. Henry and his team of dedicated professionals offer a wide range of medical treatments and services to patients of all ages. With a focus on personalized care and a commitment to improving the health and well-being of their patients, David H. Henry, MD is a trusted provider in the community. Whether you are in need of a routine check-up or more specialized medical attention, you can count on the experienced team at David H. Henry, MD to provide compassionate and comprehensive care.

Helixate FS is a health institution located at 1020 1st Avenue, King of Prussia, Pennsylvania, United States. Vita means life, and it is the platform for sharing the stories of biotech's promise to patients and public health. Helixate FS is a part of biotechnology leader CSL Behring, offering a wide range of quality plasma-derived and recombinant therapies. CSL Seqirus, a branch of CSL, is one of the largest influenza vaccine providers in the world. The institution focuses on research and development in plasma protein technology, recombinant technology, cell and gene therapy, and vaccines technology. Innovation is a core value at CSL, supporting collaborative innovation through awards and grants to researchers globally. The institution is committed to sustainability, with a goal of reducing emissions by 40% by 2030. CSL also emphasizes diversity, equity, and inclusion in its mission and values. Whether you are a student or a professional, consider CSL for a promising future in biotherapeutics. Visit Helixate FS for innovative therapies in immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. The institution is dedicated to delivering value and enhancing patient experience, with a focus on rare diseases. Patients are at the heart of Helixate FS, driving the commitment to transparency and collaboration. Explore inspiring stories on the digital storytelling page, Vita. Healthcare professionals can learn more about CSL Behring through global congresses and events. CSL Plasma, operated by CSL Behring, is one of the world's largest plasma collection networks, ensuring the manufacturing and delivery of life-saving therapies worldwide.